Fulcrum Therapeutics Inc (FULC)
Who owns Fulcrum Therapeutics Inc (FULC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.0% of the shares are freely tradable; institutional investors hold 116.3%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 8.60 | 6,561,111 | +0.0 | 03/31/2026 |
| RA Capital Management, LLC | 7.93 | 6,053,960 | +0.0 | 03/31/2026 |
| BlackRock Inc | 7.07 | 5,390,593 | +26.4 | 03/31/2026 |
| TCG Crossover Management, LLC | 6.88 | 5,250,000 | +0.0 | 03/31/2026 |
| BRAIDWELL LP | 4.11 | 3,134,922 | +2.4 | 03/31/2026 |
| Nantahala Capital Management, LLC | 4.00 | 3,050,040 | -29.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.53 | 2,692,948 | +0.0 | 03/31/2026 |
| Siren, L.L.C. | 3.08 | 2,350,000 | +20.5 | 03/31/2026 |
| First Turn Management LLC | 2.96 | 2,256,109 | +19.2 | 03/31/2026 |
| Aberdeen Group PLC | 2.90 | 2,211,953 | +76.4 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 17. Jul 2026 | Tang Kevin | 10% Owner | Buy | 50,945 | 3.52 | 179,326 |
| 16. Jul 2026 | Tang Kevin | 10% Owner | Buy | 116,671 | 3.56 | 415,349 |
| 15. Jul 2026 | Tang Kevin | 10% Owner | Buy | 107,377 | 3.56 | 382,262 |
| 14. Jul 2026 | Tang Kevin | 10% Owner | Buy | 75,952 | 3.58 | 271,908 |
| 14. Jul 2026 | Tang Kevin | 10% Owner | Buy | 53,651 | 3.56 | 190,998 |
| 13. Jul 2026 | Tang Kevin | 10% Owner | Buy | 12,966 | 3.54 | 45,900 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.